Oncotarget: Inhibition of resistant triple-negative breast cancer cells

(Impact Journals LLC) The Oncotarget author's analyses of protein markers of epithelial-to-mesenchymal transition indicated that treatments with 6-mercaptopurine and/or 5-azacitidine do not significantly reverse this process in their model.